151 related articles for article (PubMed ID: 19245874)
21. SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes.
Zawada AM; Rogacev KS; Hummel B; Grün OS; Friedrich A; Rotter B; Winter P; Geisel J; Fliser D; Heine GH
Circ Cardiovasc Genet; 2012 Dec; 5(6):611-20. PubMed ID: 23074332
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients.
Heil SG; Riksen NP; Boers GH; Smulders Y; Blom HJ
Mol Genet Metab; 2007 May; 91(1):55-60. PubMed ID: 17336565
[TBL] [Abstract][Full Text] [Related]
23. Hyperhomocysteinaemia in chronic kidney disease: focus on transmethylation.
van Guldener C; Stam F; Stehouwer CD
Clin Chem Lab Med; 2005; 43(10):1026-31. PubMed ID: 16197293
[TBL] [Abstract][Full Text] [Related]
24. Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers.
Fux R; Kloor D; Hermes M; Röck T; Proksch B; Grenz A; Delabar U; Bücheler R; Igel S; Mörike K; Gleiter CH; Osswald H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F786-92. PubMed ID: 15855656
[TBL] [Abstract][Full Text] [Related]
25. Global protein and histone arginine methylation are affected in a tissue-specific manner in a rat model of diet-induced hyperhomocysteinemia.
Esse R; Florindo C; Imbard A; Rocha MS; de Vriese AS; Smulders YM; Teerlink T; Tavares de Almeida I; Castro R; Blom HJ
Biochim Biophys Acta; 2013 Oct; 1832(10):1708-14. PubMed ID: 23707560
[TBL] [Abstract][Full Text] [Related]
26. Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice.
Li W; Liu H; Yu M; Zhang X; Zhang M; Wilson JX; Huang G
J Nutr Biochem; 2015 Aug; 26(8):883-91. PubMed ID: 25959374
[TBL] [Abstract][Full Text] [Related]
27. Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
Xiao Y; Huang W; Zhang J; Peng C; Xia M; Ling W
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):60-70. PubMed ID: 25359864
[TBL] [Abstract][Full Text] [Related]
28. Adverse effects of hyperhomocysteinemia and their management by folic acid.
Perna AF; De Santo NG; Ingrosso D
Miner Electrolyte Metab; 1997; 23(3-6):174-8. PubMed ID: 9387111
[TBL] [Abstract][Full Text] [Related]
29. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
30. Folinic Acid Increases Protein Arginine Methylation in Human Endothelial Cells.
Esse R; Teerlink T; Koolwijk P; Tavares de Almeida I; Blom HJ; Castro R
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29587354
[TBL] [Abstract][Full Text] [Related]
31. [Folic acid prevents Bcl-2 hypomethylation in rats with hyperhomocysteinemia].
Cong G; Jia S; Luo C; Wang Y
Wei Sheng Yan Jiu; 2012 Mar; 41(2):268-72. PubMed ID: 22611939
[TBL] [Abstract][Full Text] [Related]
32. Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation.
Chiang EP; Wang YC; Chen WW; Tang FY
J Clin Endocrinol Metab; 2009 Mar; 94(3):1017-25. PubMed ID: 19088160
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
[TBL] [Abstract][Full Text] [Related]
34. Homocysteine metabolism in renal failure.
Perna AF; Ingrosso D; Satta E; Lombardi C; Acanfora F; De Santo NG
Curr Opin Clin Nutr Metab Care; 2004 Jan; 7(1):53-7. PubMed ID: 15090904
[TBL] [Abstract][Full Text] [Related]
35. Epigenetics and the uremic phenotype: a matter of balance.
Stenvinkel P; Ekström TJ
Contrib Nephrol; 2008; 161():55-62. PubMed ID: 18451658
[TBL] [Abstract][Full Text] [Related]
36. Genetic and epigenetic regulation of BHMT is associated with folate therapy efficacy in hyperhomocysteinaemia.
Li D; Yang J; Zhao Q; Zhang C; Ren B; Yue L; Du B; Godfrey O; Huang X; Zhang W
Asia Pac J Clin Nutr; 2019; 28(4):879-887. PubMed ID: 31826386
[TBL] [Abstract][Full Text] [Related]
37. Homocysteine in uremia.
Perna AF; Ingrosso D; Lombardi C; Cesare CM; Acantora F; Satta E; De Santo NG
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S123-6. PubMed ID: 12612968
[TBL] [Abstract][Full Text] [Related]
38. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
[TBL] [Abstract][Full Text] [Related]
39. Notable epigenetic role of hyperhomocysteinemia in atherogenesis.
Zhou S; Zhang Z; Xu G
Lipids Health Dis; 2014 Aug; 13():134. PubMed ID: 25142226
[TBL] [Abstract][Full Text] [Related]
40. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
